Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Operating Income Growth
5.10%
TTM · Period ending:
BIO Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported5.10%period ending
Latest reported5.10%period ending
BIO TTM Operating Income YoY % (31.37% → 5.10%)
Year-over-year change
High-resolution chart · PNG
BIO operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 55.856% | |
| 56.8707% | |
| 37.6639% | |
| 42.5822% | |
| 38.4307% | |
| 44.6023% | |
| 55.9486% | |
| 64.2336% | |
| 39.7924% | |
| 18.8356% | |
| 16.0448% | |
| -10.7492% | |
| -19.0476% | |
| -24.3523% | |
| -36.1905% | |
| -28.103% | |
| -14.7971% | |
| -5.8537% | |
| 6.0606% | |
| 9.4872% | |
| 9.6859% | |
| 7.6115% | |
| 7.9019% | |
| 37.3239% | |
| 66.8122% | |
| 129.5181% | |
| 256.3107% | |
| 101.4184% | |
| 47.7419% | |
| 71.134% | |
| -29.4521% | |
| 2.9197% | |
| -1.2739% | |
| -59.0717% | |
| -33.9367% | |
| -48.3019% | |
| -38.4314% | |
| -7.4219% | |
| -9.4262% | |
| 26.7943% | |
| 25% | |
| 20.1878% | |
| -65.3901% | |
| 134.8915% | |
| 217.2414% | |
| -17.1206% | |
| 254.2714% | |
| -228.2655% | |
| -144.0506% | |
| -12.585% | |
| 21.3415% | |
| 34.5821% | |
| 47.3881% | |
| 52.3316% | |
| 38.9831% | |
| 32.9502% | |
| 31.3725% |